Synthego

Synthego

Synthego

Synthego is a leading provider of synthetic RNA solutions for #CRISPR Genome Engineering.
Type
B2b
Founded
2012
Raised
$259.3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$100,000,000
Venture capital (Series D) - 2020
Intel Capital Menlo Ventures Founders Fund +3
$110,000,000
Venture capital (Series C) - 2018
Menlo Ventures Founders Fund 8VC
Team Size
10+
Employees
$100,000,000 Venture capital (Series D)
VentureBeat , FinSMEs

Synthego raises $100 million for AI-driven gene editing

$110,000,000 Venture capital (Series C)
FinSMEs , StartupWorld , PE HUB

Synthego Raises $110M in Series C financing

Funding Science
TechCrunch , VentureBeat

Synthego raises $110 million to make gene editing technologies more accessible

Robotics Science
TechCrunch

Synthego's new products give scientists access to edited genetic material

Science
Undisclosed funding
PE HUB

Intel Capital backs Synthego

TechCrunch

Synthego co-founder Paul Dabrowski is coming to Disrupt New York 2017

Science Startup events
$41,000,000 Venture capital (Series B)
New York Times Bits

Synthego Raises $41 Million From Investors, Including a Top Biochemist